
AREV Life Sciences Global Corp. Stock Analysis AREV.CN
AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well brands. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti-viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles. Its Ready-to-Use Therapeutic Food (RUTF) for Severe Acute Malnutrition (SAM), with its branded RUTF known as SUS-TAINN (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs), and RESTORE is under development.
Read More AREV Life Sciences Global Corp (AREV.CN) Chart
Key Statistics of AREV Life Sciences Global Corp (AREV.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.09Volume
1000.00P/E Ratio (TTM)
-52 Week Range
Market Cap
2.84MAvg. Volume
13.78KDividend Yield
-Financial Metrics & Statements of AREV Life Sciences Global Corp (AREV.CN)
FAQ's for AREV Life Sciences Global Corp (AREV.CN)
- According to Musaffa’s Shariah screening methodology, AREV Life Sciences Global Corp (AREV.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.